RenovoRx, Inc.

RNXT

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001574094

SEC filings (opens in a new tab)

No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding RenovoRx, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of RNXT: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	11	13	+2
Shares	1.19M	1.23M	+42.2K (+3.5%)
Value	$2.35M	$2.49M	+$134.0K (+5.7%)

New holders (3)

Institutions that held RenovoRx, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to RNXT in Q3 2022
Institution	Shares	Value	% of portfolio
Geode Capital Management, LLC	34,302	$69.0K	0.00%
Colony Group LLC	15,741	$32.0K	0.00%
Affinity Capital Advisors, LLC	11,250	$23.0K	0.01%

Sold out (1)

Institutions that held RenovoRx, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of RNXT in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Sterling Investment Advisors, Ltd.	20	$0